GEN Exclusives
Modifications to Histones Affect Gene Expression and Cell Fate Decisions
Predictions for 2017
Old Becomes Fresh Again
Proteases in Some Cancer Cells Have the Capability to Break Antibodies by Taking Them Off Their Hinges
GEN News Highlights
Novartis’ Kymriah Wins FDA Approval as Very first CAR-T Cancer Therapy
The FDA today approved Novartis` Kymriah (tisagenlecleucel), with the agency hailing the chimeric antigen receptor T-cell (CAR-T) treatment as the very first gene therapy to be available in the U.S. Contine reading